HEADER TRANSFERASE/TRANSFERASE INHIBITOR 13-MAY-15 4ZSA TITLE CRYSTAL STRUCTURE OF FGFR1 KINASE DOMAIN IN COMPLEX WITH 7N COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 458-765; COMPND 5 SYNONYM: FGFR-1,BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1,BFGF-R-1, COMPND 6 FMS-LIKE TYROSINE KINASE 2,FLT-2,N-SAM,PROTO-ONCOGENE C-FGR; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS FGFR1 INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Q.F.LIU,Y.C.XU REVDAT 3 08-NOV-23 4ZSA 1 SOURCE REMARK REVDAT 2 22-JUL-15 4ZSA 1 JRNL REVDAT 1 17-JUN-15 4ZSA 0 JRNL AUTH J.LIU,X.PENG,Y.DAI,W.ZHANG,S.REN,J.AI,M.GENG,Y.LI JRNL TITL DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL FGFR JRNL TITL 2 INHIBITORS BEARING AN INDAZOLE SCAFFOLD. JRNL REF ORG.BIOMOL.CHEM. V. 13 7643 2015 JRNL REFN ESSN 1477-0539 JRNL PMID 26080733 JRNL DOI 10.1039/C5OB00778J REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.37 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.150 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 47527 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.220 REMARK 3 FREE R VALUE TEST SET COUNT : 2004 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.3710 - 4.8161 0.95 3380 145 0.1818 0.2157 REMARK 3 2 4.8161 - 3.8243 0.99 3466 151 0.1639 0.2237 REMARK 3 3 3.8243 - 3.3413 0.99 3439 154 0.1924 0.2346 REMARK 3 4 3.3413 - 3.0360 0.99 3458 149 0.2173 0.2931 REMARK 3 5 3.0360 - 2.8185 0.99 3380 152 0.2367 0.2589 REMARK 3 6 2.8185 - 2.6524 0.98 3361 154 0.2249 0.2744 REMARK 3 7 2.6524 - 2.5196 0.97 3345 143 0.2297 0.2879 REMARK 3 8 2.5196 - 2.4100 0.96 3265 141 0.2275 0.3005 REMARK 3 9 2.4100 - 2.3172 0.94 3257 145 0.2182 0.2604 REMARK 3 10 2.3172 - 2.2373 0.93 3188 142 0.2295 0.2958 REMARK 3 11 2.2373 - 2.1673 0.90 3092 132 0.2310 0.2996 REMARK 3 12 2.1673 - 2.1054 0.90 3078 136 0.2456 0.2950 REMARK 3 13 2.1054 - 2.0500 0.87 2949 129 0.2572 0.3227 REMARK 3 14 2.0500 - 2.0000 0.84 2865 131 0.2607 0.3038 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.760 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.03 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4686 REMARK 3 ANGLE : 1.143 6339 REMARK 3 CHIRALITY : 0.044 687 REMARK 3 PLANARITY : 0.006 809 REMARK 3 DIHEDRAL : 15.222 1773 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4ZSA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-JUN-15. REMARK 100 THE DEPOSITION ID IS D_1000209794. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-SEP-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : COOT REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50138 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.48600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.3 REMARK 200 STARTING MODEL: 1AGW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS PH 6.5, 0.3M (NH4)2SO4, REMARK 280 15-20% PEG10000, 5% EG, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.95500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.59050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.95500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.59050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 ALA B 458 REMARK 465 GLY B 459 REMARK 465 VAL B 460 REMARK 465 SER B 461 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 ALA B 645 REMARK 465 ARG B 646 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 SER B 762 REMARK 465 ASN B 763 REMARK 465 GLN B 764 REMARK 465 GLU B 765 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 464 N CA CB CG CD OE1 OE2 REMARK 470 LYS A 502 CG CD CE NZ REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 517 CB CG CD CE NZ REMARK 470 ASP A 519 CB CG OD1 OD2 REMARK 470 GLU A 522 CG CD OE1 OE2 REMARK 470 LYS B 482 CG CD CE NZ REMARK 470 LYS B 502 CG CD CE NZ REMARK 470 ASP B 503 CG OD1 OD2 REMARK 470 LYS B 504 CG CD CE NZ REMARK 470 ARG B 507 CB CG CD NE CZ NH1 NH2 REMARK 470 VAL B 508 CB CG1 CG2 REMARK 470 LYS B 655 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 622 -18.38 78.41 REMARK 500 ASP A 647 93.28 -57.96 REMARK 500 HIS A 650 -15.43 161.37 REMARK 500 TRP A 737 30.10 -97.95 REMARK 500 ASP B 468 89.71 -152.88 REMARK 500 ASN B 506 23.45 -142.54 REMARK 500 ARG B 622 -25.00 74.73 REMARK 500 ARG B 675 52.13 35.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 HIS A 649 HIS A 650 -137.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4UT A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4UT B 801 DBREF 4ZSA A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 4ZSA B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 4ZSA ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4ZSA SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQADV 4ZSA ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4ZSA SER B 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQRES 1 A 308 ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO ARG SEQRES 2 A 308 TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS PRO SEQRES 3 A 308 LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA GLU SEQRES 4 A 308 ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL THR SEQRES 5 A 308 LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR GLU SEQRES 6 A 308 LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET MET SEQRES 7 A 308 LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU LEU SEQRES 8 A 308 GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE VAL SEQRES 9 A 308 GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU GLN SEQRES 10 A 308 ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN PRO SEQRES 11 A 308 SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP LEU SEQRES 12 A 308 VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU TYR SEQRES 13 A 308 LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA ALA SEQRES 14 A 308 ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS ILE SEQRES 15 A 308 ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE ASP SEQRES 16 A 308 TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL LYS SEQRES 17 A 308 TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR THR SEQRES 18 A 308 HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP SEQRES 19 A 308 GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY VAL SEQRES 20 A 308 PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY HIS SEQRES 21 A 308 ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU TYR SEQRES 22 A 308 MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER GLN SEQRES 23 A 308 ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP ARG SEQRES 24 A 308 ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 308 ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO ARG SEQRES 2 B 308 TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS PRO SEQRES 3 B 308 LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA GLU SEQRES 4 B 308 ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL THR SEQRES 5 B 308 LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR GLU SEQRES 6 B 308 LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET MET SEQRES 7 B 308 LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU LEU SEQRES 8 B 308 GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE VAL SEQRES 9 B 308 GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU GLN SEQRES 10 B 308 ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN PRO SEQRES 11 B 308 SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP LEU SEQRES 12 B 308 VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU TYR SEQRES 13 B 308 LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA ALA SEQRES 14 B 308 ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS ILE SEQRES 15 B 308 ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE ASP SEQRES 16 B 308 TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL LYS SEQRES 17 B 308 TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR THR SEQRES 18 B 308 HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP SEQRES 19 B 308 GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY VAL SEQRES 20 B 308 PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY HIS SEQRES 21 B 308 ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU TYR SEQRES 22 B 308 MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER GLN SEQRES 23 B 308 ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP ARG SEQRES 24 B 308 ILE VAL ALA LEU THR SER ASN GLN GLU HET 4UT A 801 34 HET 4UT B 801 34 HETNAM 4UT 4-(4-ETHYLPIPERAZIN-1-YL)-N-[6-(3-METHOXYPHENYL)-2H- HETNAM 2 4UT INDAZOL-3-YL]BENZAMIDE FORMUL 3 4UT 2(C27 H29 N5 O2) FORMUL 5 HOH *266(H2 O) HELIX 1 AA1 PRO A 474 ASP A 476 5 3 HELIX 2 AA2 THR A 521 GLY A 539 1 19 HELIX 3 AA3 ASN A 568 ALA A 575 1 8 HELIX 4 AA4 SER A 596 LYS A 617 1 22 HELIX 5 AA5 ALA A 625 ARG A 627 5 3 HELIX 6 AA6 LEU A 662 MET A 667 5 6 HELIX 7 AA7 ALA A 668 ARG A 675 1 8 HELIX 8 AA8 THR A 678 THR A 695 1 18 HELIX 9 AA9 PRO A 705 GLU A 715 1 11 HELIX 10 AB1 THR A 726 TRP A 737 1 12 HELIX 11 AB2 VAL A 740 ARG A 744 5 5 HELIX 12 AB3 THR A 746 THR A 761 1 16 HELIX 13 AB4 PRO B 474 ASP B 476 5 3 HELIX 14 AB5 GLY B 485 ALA B 488 5 4 HELIX 15 AB6 THR B 521 GLY B 539 1 19 HELIX 16 AB7 ASN B 568 ALA B 575 1 8 HELIX 17 AB8 SER B 596 LYS B 617 1 22 HELIX 18 AB9 ALA B 625 ARG B 627 5 3 HELIX 19 AC1 LEU B 662 MET B 667 5 6 HELIX 20 AC2 ALA B 668 ASP B 674 1 7 HELIX 21 AC3 THR B 678 THR B 695 1 18 HELIX 22 AC4 PRO B 705 GLU B 715 1 11 HELIX 23 AC5 THR B 726 TRP B 737 1 12 HELIX 24 AC6 VAL B 740 ARG B 744 5 5 HELIX 25 AC7 THR B 746 LEU B 760 1 15 SHEET 1 AA1 5 LEU A 478 LEU A 484 0 SHEET 2 AA1 5 GLN A 491 ILE A 498 -1 O GLU A 496 N VAL A 479 SHEET 3 AA1 5 VAL A 508 MET A 515 -1 O VAL A 513 N VAL A 493 SHEET 4 AA1 5 TYR A 558 GLU A 562 -1 O VAL A 561 N ALA A 512 SHEET 5 AA1 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 AA2 2 VAL A 629 VAL A 631 0 SHEET 2 AA2 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 AA3 5 LEU B 478 PRO B 483 0 SHEET 2 AA3 5 VAL B 492 ILE B 498 -1 O LEU B 494 N GLY B 481 SHEET 3 AA3 5 VAL B 508 LYS B 514 -1 O THR B 509 N ALA B 497 SHEET 4 AA3 5 TYR B 558 GLU B 562 -1 O VAL B 561 N ALA B 512 SHEET 5 AA3 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 AA4 2 VAL B 629 VAL B 631 0 SHEET 2 AA4 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 SITE 1 AC1 13 LEU A 484 GLY A 485 PHE A 489 ALA A 512 SITE 2 AC1 13 LYS A 514 GLU A 531 VAL A 561 GLU A 562 SITE 3 AC1 13 TYR A 563 ALA A 564 SER A 565 GLY A 567 SITE 4 AC1 13 LEU A 630 SITE 1 AC2 12 PHE B 489 ALA B 512 LYS B 514 GLU B 531 SITE 2 AC2 12 VAL B 561 GLU B 562 TYR B 563 ALA B 564 SITE 3 AC2 12 SER B 565 GLY B 567 GLU B 571 LEU B 630 CRYST1 209.910 57.181 65.550 90.00 107.47 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004764 0.000000 0.001499 0.00000 SCALE2 0.000000 0.017488 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015993 0.00000